A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients. (2017). International Journal of Biomedical and Advance Research, 8(11), 407-415. https://doi.org/10.7439/ijbar.v8i11.4474